Updated 8 a.m. May 2: With in-person capacity having been reaached, the organizers have added a livestream option. Register here.

A symposium named after Edwin G. Krebs, the only Nobel laureate to date from UC Davis, will feature a keynote address by UC Berkeley Nobel Laureate Jennifer Doudna.

The inaugural Krebs Symposium, hosted by the School of Medicine’s Department of Biochemistry and Molecular Medicine, is scheduled from noon to 5 p.m. Monday, May 15, at the Conference Center on the Davis campus.

Doudna, a biochemist, is a Howard Hughes Medical Institute Investigator and founder of the Innovative Genomics Institute at Berkeley.

She won the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier, for the co-development of CRISPR-Cas9. The genome editing breakthrough has revolutionized biomedicine, enabling scientists to change or remove genes quickly and with great precision.

Krebs (1918-2009) was the founding chair of biological chemistry in the School of Medicine, serving from 1968 to 1977 when he returned to the University of Washington. He shared the Nobel Prize in Physiology or Medicine in 1992 with Edmond H. Fischer for “their discoveries concerning reversible protein phosphorylation as a biological regulatory mechanism."

Attendance at the Krebs Symposium is limited to 250 people. Lunch will be provided at the beginning of the event. Faculty, postdoctoral scholars, staff and students are invited to sign up with their UC Davis email address here. The deadline for registration is Monday (May 1).

For more information, send an email to Adriane Joo, chief administrative officer for the Department of Biochemistry and Molecular Medicine.

Lisa Howard is a senior public information officer in UC Davis Health Communications and Media Relations. She can be reached at 916-752-6394 or lehoward@ucdavis.edu.